3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
32
Metastatic Castration-resistant Prostate Cancer
3
Prostatic Neoplasms, Castration-Resistant
2
Prostate Cancer Metastatic
2
Urogenital Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Prostatic Diseases
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
NSCLC Harboring NRG1 Fusion
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Castration-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Male Urogenital Diseases
1
Genital Neoplasms, Male
1
Fatigue
1
Depression
1
Advanced Prostate Cancer
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
pembrolizumab
2
cabozantinib
2
sodium thiosulfate
1
relacorilant
1
fludarabine phosphate
1
cemiplimab
1
Nivolumab
1
Ipilimumab
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Floxuridine
1
Dexamethasone
1
Cytoreduction Surgical Procedures
1
Cyclophosphamide
1
Cisplatin
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adrenocortical Carcinoma
×
Abiraterone Acetate
×
90 days
×
Clear all
No trials found.